S Hägele-Link
[The new Parkinson's disease pain classification system (PD-PCS)].
Mylius V, Perez Lloret S, Brook C, Krüger M, Hägele-Link S, Gonzenbach R, Kassubek J, Bohlhalter S, Lefaucheur J, Timmermann L, Kägi G, Brugger F, Ciampi de Andrade D, Möller J. [The new Parkinson's disease pain classification system (PD-PCS)]. Nervenarzt 2022; 93:1019-1027.
28.01.2022[The new Parkinson's disease pain classification system (PD-PCS)].
28.01.2022Nervenarzt 2022; 93:1019-1027
Mylius V, Perez Lloret S, Brook C S, Krüger M T, Hägele-Link S, Gonzenbach Roman, Kassubek Jan, Bohlhalter Stephan, Lefaucheur J P, Timmermann L, Kägi Georg, Brugger Florian, Ciampi de Andrade D, Möller J C
Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial
Schreglmann S, Waldvogel D, Zimmerli L, Götze O, Hägele-Link S, Kägi G, Epprecht L, Sommerauer M, Büchele F, Baumann C. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial. Eur J Neurol 2017
22.02.2017Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial
22.02.2017Eur J Neurol 2017
Schreglmann S R, Waldvogel D, Zimmerli L, Götze O, Hägele-Link S, Kägi Georg, Epprecht L, Sommerauer M, Büchele F, Baumann C R